Collagen Solutions wins brain and spinal injury supply deal

The AIM-listed biomaterials company, which has its main manufacturing plant in Glasgow, has agreed terms with Turkish firm Desu Medical.

That will involve it supplying soluble collagen which will be used in the production of implants for a brain membrane called dura, which surrounds and protects the brain as spinal cord, as well as spinal fusion implants.

Loading article content

These will then be used in the treatment of injuries by stimulating greater dura and bone generation through the use of highly concentrated collagen.

Desu's brain implant is called Decoll and its spinal one is known as Debone.

Stewart White, chief executive of Collagen Solutions, said: "This agreement is the culmination of a long association with Desu Medical during which we have been supplying developmental quantities of medical grade collagen.

"Winning this contract is based on our ability to convince such an established company that we can supply a medical grade collagen suitable for manufacturing their products consistently and to order, for the life of the product line.

"It is important for companies to secure their source of the collagen early in the commercialisation process as this will become part of the regulatory submissions for their products around the World.

Mehmet Sorar, chief executive of Desu Medical, said: "We are equally pleased to announce our agreement with Collagen Solutions. Our aim is to make our products leading brands in the market.

"We hope that our collaboration will last for many years to come."

Read this article:
Collagen Solutions wins brain and spinal injury supply deal